Paratek Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Paratek Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Paratek Pharmaceuticals Inc
Access all reports
Paratek Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for infectious diseases. The company specializes in antibiotics that address serious bacterial infections, including drug-resistant strains. Paratek's products are designed to provide effective treatment options for conditions such as skin infections and community-acquired bacterial pneumonia. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
PRTK
Country
🇺🇸 United States